Letter: ciclosporin or infliximab in acute ulcerative colitis - still undecided; authors' reply

被引：0
|
作者：
Croft, A. [1 ]
Walsh, A. [2 ]
Doecke, J. [3 ,4 ,5 ]
Radford-Smith, G. [1 ,6 ,7 ]
机构：
[1] Royal Brisbane & Womens Hosp, Dept Gastroenterol, Brisbane, Qld, Australia
[2] St Vincents Hosp, Dept Gastroenterol, Sydney, NSW 2010, Australia
[3] Royal Brisbane & Womens Hosp, Australian E Hlth Res Ctr, Brisbane, Qld, Australia
[4] CSIRO Preventat Hlth Flagship, Melbourne, Vic, Australia
[5] Macquarie Univ, CSIRO Math & Informat Sci, Sydney, NSW 2109, Australia
[6] Queensland Inst Med Res, IBD Grp, Brisbane, Qld 4006, Australia
[7] Univ Queensland, Sch Med, Brisbane, Qld, Australia
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2013年 / 38卷 / 08期
关键词：
D O I：
10.1111/apt.12474
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：993 / 993
页数：1
相关论文
共 50 条
  • [31] Hospitalization and treatment costs for acute, severe, steroid-refractory ulcerative colitis: Infliximab beats ciclosporin
    Thwaites, P.
    Irwin, J.
    Walker, N.
    McMahon, A.
    Sewell, K.
    Croft, A.
    Clark, D.
    Howlett, M.
    Radford-Smith, G. L.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 123 - 123
  • [32] Editorial: what can be done when infliximab stops working in ulcerative colitis? Authors' reply
    Amiot, A.
    Stefanescu, C.
    Bouhnik, Y.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (01) : 165 - 165
  • [33] Effect of Accelerated Infliximab Induction on Outcomes of Acute Severe Ulcerative Colitis Reply
    Ananthakrishnan, Ashwin N.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (09) : 1919 - 1919
  • [34] Commentary: salvage medical therapy for acute severe colitis - ciclosporin or infliximab? Author's reply
    Croft, A.
    Walsh, A.
    Doecke, J.
    Radford-Smith, G.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (08) : 989 - 990
  • [35] Letter: stool adalimumab detection in ulcerative colitis and Crohn's disease - authors' reply
    Rosen, M. J.
    Minar, P.
    Vinks, A. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (02) : 241 - 241
  • [36] Letter: Comparing first-line infliximab and vedolizumab for ulcerative colitis-It depends on how you use the drug. Authors' reply
    Bokemeyer, Bernd
    Plachta-Danielzik, Sandra
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (01) : 142 - 143
  • [37] INFLIXIMAB OR CICLOSPORIN: PATIENTS' TREATMENT PREFERENCES AND THE IMPACT OF ULCERATIVE COLITIS (UC) ON THEIR LIVES
    Seagrove, A.
    Rapport, F.
    Williams, J.
    GUT, 2014, 63 : A65 - A65
  • [38] Infliximab for the treatment of acute exacerbations of ulcerative colitis
    Bryan, S.
    Andronis, L.
    Hyde, C.
    Connock, M.
    Fry-Smith, A.
    Wang, D.
    HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 9 - 15
  • [39] Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab
    Croft, A.
    Walsh, A.
    Doecke, J.
    Cooley, R.
    Howlett, M.
    Radford-Smith, G.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (03) : 294 - 302
  • [40] Editorial: is enteral nutrition back in acute severe ulcerative colitis? Authors' reply
    Sahu, Pabitra
    Kedia, Saurabh
    Kumar Vuyyuru, Sudheer
    Travis, Simon
    Ahuja, Vineet
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (06) : 747 - 748
12345